Evidence map›Paper›PMID 31703344›Full record

ArticleCancers2019

Coexisting Germline

Danuta Gąsior-Perczak, Artur Kowalik, Agnieszka Walczyk, Monika Siołek, Krzysztof Gruszczyński, Iwona Pałyga, Estera Mikina, Tomasz Trybek, Janusz Kopczyński, Ryszard Mężyk and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Incidence of theCancers · 2021
    Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Danuta Gąsior-PerczakEndocrinology, Holycross Cancer Centre, S. Artwińskiego St. 3, 25-734 Kielce, Poland.ORCID 0000-0003-0936-4890
Artur KowalikMolecular Diagnostics, Holycross Cancer Centre, S. Artwińskiego Str. 3, 25-734 Kielce, Poland.ORCID 0000-0002-3718-999X
Agnieszka WalczykEndocrinology, Holycross Cancer Centre, S. Artwińskiego St. 3, 25-734 Kielce, Poland.
Monika SiołekGenetic Clinic, Holycross Cancer Centre, 25-734 Kielce, Poland.
Krzysztof GruszczyńskiMolecular Diagnostics, Holycross Cancer Centre, S. Artwińskiego Str. 3, 25-734 Kielce, Poland.
Iwona PałygaEndocrinology, Holycross Cancer Centre, S. Artwińskiego St. 3, 25-734 Kielce, Poland.
Estera MikinaEndocrinology, Holycross Cancer Centre, S. Artwińskiego St. 3, 25-734 Kielce, Poland.
Tomasz TrybekEndocrinology, Holycross Cancer Centre, S. Artwińskiego St. 3, 25-734 Kielce, Poland.
Janusz KopczyńskiSurgical Pathology, Holycross Cancer Centre, S. Artwińskiego Str. 3, 25-734 Kielce, Poland.
Ryszard MężykCancer Epidemiology, Holycross Cancer Center, 25-734 Kielce, Poland.
Stanisław GóźdźThe Faculty of Health Sciences, Jan Kochanowski University, IX Wieków Kielc Av. 19, 25-319 Kielce, Poland.
Aldona KowalskaEndocrinology, Holycross Cancer Centre, S. Artwińskiego St. 3, 25-734 Kielce, Poland.ORCID 0000-0001-5647-5898
Holy Cross University · PLJan Kochanowski University · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BRAF mutationCHEK2 mutationpapillary thyroid cancerresponse to therapyrisk stratification

Identifiers

PMID31703344
PMCPMC6896084
OpenAlexW2986382041

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.